AndrewHLimperMD

Critical Care Medicine, Pleural Disease

Professor, Internal Medicine, Mayo Medical School

Dr. Limper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1989
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1986
University of Illinois College of MedicineClass of 1984

PubMed

Abstracts/Posters

Incidence and Outcomes of Pneumocystis pneumonia When Utilizing PCR-Based Diagnosis in Patients with Hodgkin Lymphoma Receiving Intensive Chemotherapy
Andrew H Limper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Other

Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in non-HIV-infected patients
Limper AH, Thomas CF
http://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-diagnosis-of-pneumocystis-
UpToDate, Wolters Kluwer Health - 2013-02-27
Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients
Limper AH, Thomas CF
http://www.uptodate.com/contents/treatment-and-prevention-of-pneumocystis-pneumonia-in-non-hiv-infec
UpToDate, Wolters Kluwer Health - 2013-02-27
Pulmonary toxicity associated with antineoplastic therapy: Cytotoxic agents
Limper AH, Maldonado F, Jett JR
http://www.uptodate.com/contents/pulmonary-toxicity-associated-with-antineoplastic-therapy-cytotoxic
UpToDate, Wolters Kluwer Health - 2013-03-28
Pulmonary toxicity associated with antineoplastic therapy: Molecularly targeted agents
Limper AH, Maldonado F, Jett JR
http://www.uptodate.com/contents/pulmonary-toxicity-associated-with-antineoplastic-therapy-molecular
UpToDate, Wolters Kluwer Health - 2013-02-27
Pulmonary toxicity associated with systemic antineoplastic therapy: Clinical presentation, diagnosis, and treatment
Limper AH, Maldonado F, Jett JR
http://www.uptodate.com/contents/pulmonary-toxicity-associated-with-systemic-antineoplastic-therapy-
UpToDate, Wolters Kluwer Health - 2012-03-29
Join now to see all

Fungal Infections Are Becoming More Frequent. Why Isn't There a Vaccine?February 10th, 2023
Fungal Infections Are Becoming More Common. Why Isn’t There a Vaccine?February 10th, 2023
New Automated Screening Tool Could Mean Earlier, More Effective Treatment for Idiopathic Pulmonary FibrosisSeptember 29th, 2022
Join now to see all

Cholesterol And Sphingolipid Perturbation Of Membrane Traffic In Human DiseaseNational Institute Of General Medical Sciences2010–2011
Pneumocystis Carinii: Macrophage And Epithelial ActivationNational Heart, Lung, And Blood Institute2008–2011
Control Of The Pneumocystis Carinii Life CycleNational Heart, Lung, And Blood Institute2004–2008
Pneumocystis Carinii: Macrophage &Epithelial ActivationNational Heart, Lung, And Blood Institute2004–2007
Nhlbi Respiration Biology Research Training GrantNational Heart, Lung, And Blood Institute2004–2007
Pneumocystis Carinii: Macrophage &Epithelial ActivationNational Heart, Lung, And Blood Institute2003
Nhlbi Respiration Biology Research Training GrantNational Heart, Lung, And Blood Institute2003
Control Of The Pneumocystis Carinii Cell CycleNational Heart, Lung, And Blood Institute1995–2003
Pneumocystis Carinii--Macrophage Uptake And ActivationNational Heart, Lung, And Blood Institute1998–2002
Nhlbi Respiratory Biology Research Training GrantNational Heart, Lung, And Blood Institute1998–2002
Surfactant Protein D In Pneumocystis/Host InteractionNational Heart, Lung, And Blood Institute1997–1999
Pneumocystis Carinii--Macrophage Uptake And ActivationNational Institute Of Allergy And Infectious Diseases1993–1997